{"id":"W2516537857","doi":"10.1002/ajh.24536","title":"Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib","year":2016,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Pfizer","keywords":"Bosutinib; Medicine; Nilotinib; Dasatinib; Internal medicine; Imatinib; Cumulative incidence; Adverse effect; Nausea; Myeloid leukemia; Gastroenterology; Oncology; Cohort","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001393114,0.0002736296,0.0007576271,0.0001882512,0.0002392122,0.000357264,0.0002784424,0.0002161262,0.0008077853],"category_scores_gemma":[0.0005554331,0.00007950892,0.0004892218,0.0001987917,0.0001385253,0.0003262218,0.0002237052,0.0007457184,0.0002733678],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003649808,"about_ca_system_score_gemma":0.0003997217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004030024,"about_ca_topic_score_gemma":0.002283857,"domain_scores_codex":[0.9997136,0.00008499213,0.00002293846,0.00003109112,0.00007245952,0.00007499764],"domain_scores_gemma":[0.9996057,0.00009100357,0.0001346434,0.00002141456,0.00003642839,0.0001107938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.06497496,0.004935441,0.1780439,0.00101151,0.001615924,0.002638574,0.0002896777,0.001724551,0.06651157,0.0003848436,0.00761948,0.6702496],"study_design_scores_gemma":[0.01675685,0.23376,0.6716598,0.0003576046,0.002078048,0.009774343,0.000195671,0.004247282,0.02536048,0.0005213786,0.03521084,0.00007775267],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880214,0.009053321,0.0004229581,0.0002541455,0.0000642238,0.0001074564,0.0004175486,0.00003635205,0.00162271],"genre_scores_gemma":[0.9959348,0.001674495,0.0002624073,0.0002615062,0.00005747171,0.00004806825,0.0008950172,0.000004316388,0.0008618385],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001393114,"threshold_uncertainty_score":0.007367551,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01464961286399839,"score_gpt":0.3128337850963781,"score_spread":0.2981841722323797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}